Friday, July 31, 2026

Alzheimer’s Breakthrough: Monthly Injections of IVL3003 vs. GB-5001A—Which is More Effective?

New long-acting injectable formulations of donepezil for Alzheimer's aim to improve adherence and efficacy, easing caregiver burdens.

Bladder Cancer: The Silent Risk You Shouldn’t Ignore After 40

May is Bladder Cancer Awareness Month; smoking increases risk. Regular screenings are vital for early detection and improved survival rates.

How International Collaboration is Revolutionizing Infectious Disease Research in Asia

Korea's Disease Control Agency establishes a framework for local medical institutions to join international clinical trials for infectious diseases.

Tag: cancer

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

2023 Cancer Statistics: Prostate Cancer Surges to Top Spot Among Men in Korea

Prostate cancer is now the most common cancer in South Korean men, reflecting demographic shifts and improved survival rates.

Nesuparib vs. Traditional Treatments: Will This New Dual-Target Cancer Drug Change the Game for Ovarian Cancer?

Onconic Therapeutics advances Nesuparib into Phase 2 trials for ovarian cancer, aiming to validate a novel re-maintenance therapy approach.

NK Cell Cancer Therapies Move Closer to Market as Matica BioLabs Partners With Ingenium

CHA Biotech's Matica BioLabs partners with Ingenium Therapeutics for NK cell therapy production, targeting cancer treatment advancements.

ABL206: First-in-Class Dual Antibody Drug Conjugate Approved for Clinical Trials in the U.S. – What This Means for Cancer Treatment

ABL Bio and Neok Bio received FDA approval for ABL206, a dual-antibody ADC, marking a key milestone in their clinical development efforts.

K-Bio Revolution: How Korean Biopharmaceuticals Are Conquering the Global Market in 2026

South Korea's pharmaceutical industry thrives with innovative drugs like botulinum toxins and cancer treatments, targeting global markets.

How Tumor Microenvironment Stiffness Fuels Cancer Aggressiveness: Key Insights from Pusan National University

A study reveals that tumor microenvironment stiffness increases cancer aggressiveness and treatment resistance, highlighting its significance in treatment strategies.

SK Biofarm, FDA Approved Radioactive Method: Will it be a Revolutionary Cancer Cure with SLK 33501?

SK Biopharmaceuticals gains FDA approval for Phase 1 trials of radiopharmaceuticals SKL35501 and SKL35502, advancing cancer treatment.

Lost Your Voice for Over Two Weeks? It Could Be More Than a Cold

Persistent hoarseness may signal laryngeal cancer, especially in those over 60. Early diagnosis is vital for effective treatment.

Smoker? Heavy Drinker? You’re at Risk for This Silent Cancer

Tongue cancer is rare yet rising among younger adults. Early detection and treatment are crucial for survival and preserving function.

Bladder Cancer: The Silent Risk You Shouldn’t Ignore After 40

May is Bladder Cancer Awareness Month; smoking increases risk. Regular screenings are vital for early detection and improved survival rates.

Cancer Gone for 3 Years? This New Drug Is Making It Happen

AbbVie's Epkinly shows 96% long-term complete remission in R/R large B-cell lymphoma patients, highlighting its effectiveness as a therapy.

New Hope for Solid Tumors? Korean Biotech Starts Phase 1 Trial of Targeted Drug

Digmbio secures 12 billion KRW for clinical trials of cancer drug DM5167 and advances treatment for degenerative brain diseases.

Cigarettes vs. DNA: Study Shows Smoking Is the Real Cancer Trigger

A study shows that smoking for over 20 years increases small-cell lung cancer risk by 54 times, highlighting smoking's dangers.

J&J Aims to Treat Cancer Before It Starts Showing Symptoms

Johnson & Johnson leads in multiple myeloma treatment, pioneering early intervention for high-risk patients with a new subcutaneous formulation.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.